NCT01663766 2021-08-19Phase I Study of Milatuzumab for Graft Versus Host DiseaseGilead SciencesPhase 1 Terminated12 enrolled
NCT01163253 2017-06-26A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisPfizerPhase 3 Terminated2,867 enrolled 77 charts
NCT01600053 2016-12-15Revlimid® as Consolidation Treatment Chronic Lymphocytic LeukemiaUniversity of California, San DiegoPhase 2 Terminated11 enrolled 4 charts